Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,788.80
(
0.70%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
104.50
(
0.30%
)
Bitcoin
80,792.68
(
-0.33%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122982
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 144357

Saturday, 06/23/2012 3:25:37 PM

Saturday, June 23, 2012 3:25:37 PM

Post# of 257566
The MS market in the US is highly fragmented and is quite sticky, so I highly doubt that BG-12 will be able to garner a 50% market share during the next 3-5 years. Copaxone is currently the US market leader with a 40% TRx share (#msg-75407417); Avonex, Rebif, Betaseron, Gilenya, and Tysabri make up the other 60%.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today